The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-UK detects South African coronavirus variant in people with no travel links

Mon, 01st Feb 2021 12:28

* Eleven cases in England with no direct connection with S.
Africa

* Public Health England says 105 cases of new variant
detected

* Mass testing to start in eight areas to contain spread
(Adds comments from health secretary, Public Health England)

By Paul Sandle

LONDON, Feb 1 (Reuters) - Eleven people in different regions
of England have tested positive for the South African
coronavirus variant without having any links to people who have
travelled, prompting mass testing in the areas to contain the
outbreak.

Britain, with the world's fifth-highest COVID-19 death toll,
has moved to tighten its borders out of concern that new
variants of the virus will undermine its vaccination drive.

To contain the new outbreaks, residents in eight areas of
the country will now be tested whether or not they are showing
symptoms, a process known as "surge testing".

There are about 10,000 people in each area. Three are in
London, two in the southeast, one in central England, one in the
east and another in the northwest.

Health minister Matt Hancock said those in the affected
areas needed to comply with the request to be tested, even if
they are asymptomatic, to break any chain of transmission.

"There's currently no evidence to suggest this variant is
any more severe," he said. "But we need to come down on it hard,
and we will."

Positive tests in the areas will be sequenced to identify
any further spread of the variant.

All viruses mutate, and scientists have identified several
variants of the coronavirus found to be more transmissible than
the original strain.

Their emergence has raised questions over whether vaccines
will still prove effective.

Public Health England said it has identified a total of 105
cases of the South African variant since Dec 22.

Scientists have said it appears to be more transmissible,
but there is no evidence that it causes more severe disease.
However, several laboratory studies have found that it reduces
vaccine and antibody therapy efficacy.

Simon Clarke, associate professor in cellular microbiology
at the University of Reading, said there was emerging evidence
to suggest the variant was less susceptible to immunity induced
by the current crop of vaccines.

"The discovery of a handful of cases with no links to travel
to Africa indicates that it might be more widespread in the
community than previously thought," he said.

"This spread, even if small in scale, needs to be brought
under control quickly, so Public Health England's house-to-house
checks and intensive testing are the right thing to do."

Public Health England's Managing Director Susan Hopkins said
the cases did not appear linked.

"They're more likely to be related to somebody who
potentially had asymptomatic infection when they came in from
abroad," she said at a news conference.

Britain is battling a new wave of COVID-19 turbocharged by
the emergence in September of a more transmissable variant found
in the southeast of England. The country's official death toll
passed 100,000 last week.
Britain is, however, making rapid progress in its vaccination
programme, with nearly 9.3 million people having received the
first shot of either the Pfizer-BioNTech or
Oxford-AstraZeneca shot.
(Reporting by Kate Holton, Michael Holden and Paul Sandle
Editing by Estelle Shirbon, Timothy Heritage and David Goodman
)

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.